List of works - Angel Garcia-Lora

A new extract of the plant Calendula officinalis produces a dual in vitro effect: cytotoxic anti-tumor activity and lymphocyte activation

scientific article

A novel preclinical murine model of immune-mediated metastatic dormancy.

scientific article published on 25 June 2014

Alterations of HLA class I expression in human melanoma xenografts in immunodeficient mice occur frequently and are associated with higher tumorigenicity.

scientific article published on 9 May 2009

Cancer immune escape: implications for immunotherapy, Granada, Spain, October 3-5, 2011

scientific article published on 21 February 2012

Class II transactivator-induced MHC class II expression in pancreatic cancer cells leads to tumor rejection and a specific antitumor memory response.

scientific article

Different regulation of PKC isoenzymes and MAPK by PSK and IL-2 in the proliferative and cytotoxic activities of the NKL human natural killer cell line.

scientific article published on 17 October 2002

Differential effect of protein-bound polysaccharide (PSK) on survival of experimental murine tumors

scientific article published on 01 March 1999

Effect of thyroid hormone-nitric oxide interaction on tumor growth, angiogenesis, and aminopeptidase activity in mice

scientific article published on 20 February 2014

Generation of MHC class I diversity in primary tumors and selection of the malignant phenotype.

scientific article

HLA and melanoma: multiple alterations in HLA class I and II expression in human melanoma cell lines from ESTDAB cell bank.

scientific article

Identification of the protein components of protein-bound polysaccharide (PSK) that interact with NKL cells.

scientific article

International conference: progress in vaccination against cancer-2006 (PIVAC 6), Granada, Spain.

scientific article published on 21 March 2007

MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to Immunotherapy.

scientific article published on 29 January 2018

MHC class I antigens and immune surveillance in transformed cells.

scientific article published on January 2007

MHC class I antigens, immune surveillance, and tumor immune escape.

scientific article

MHC class I molecules act as tumor suppressor genes regulating the cell cycle gene expression, invasion and intrinsic tumorigenicity of melanoma cells.

scientific article published on 4 January 2012

MHC class I-deficient metastatic tumor variants immunoselected by T lymphocytes originate from the coordinated downregulation of APM components.

scientific article published in September 2003

Metastases in immune-mediated dormancy: a new opportunity for targeting cancer

scientific article

Preclinical modeling of EGFR-specific antibody resistance: oncogenic and immune-associated escape mechanisms.

scientific article published on 26 August 2013

Protein-bound polysaccharide K and interleukin-2 regulate different nuclear transcription factors in the NKL human natural killer cell line.

scientific article published on June 2001

Restoration of MHC-I on Tumor Cells by Fhit Transfection Promotes Immune Rejection and Acts as an Individualized Immunotherapeutic Vaccine

scientific article published on 12 June 2020

Role of altered expression of HLA class I molecules in cancer progression.

scientific article published on January 2007

Selective upregulation of MHC class I expression in metastatic colonies derived from tumor clones of a murine fibrosarcoma.

scientific article

T lymphocytes restrain spontaneous metastases in permanent dormancy.

scientific article published on 14 February 2014

The immunomodulator PSK induces in vitro cytotoxic activity in tumour cell lines via arrest of cell cycle and induction of apoptosis

scientific article published in 2008

The pro-oxidant buthionine sulfoximine (BSO) reduces tumor growth of implanted Lewis lung carcinoma in mice associated with increased protein carbonyl, tubulin abundance, and aminopeptidase activity

scientific article published on 11 May 2014

The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape.

scientific article published on 7 April 2004

The tumour suppressor Fhit positively regulates MHC class I expression on cancer cells ⬇️

scientific article published on May 23, 2012

The urgent need to recover MHC class I in cancers for effective immunotherapy

scientific article

Total loss of HLA class I expression on a melanoma cell line after growth in nude mice in absence of autologous antitumor immune response.

scientific article

Tumour immunology, vaccination and escape strategies

scientific article (publication date: June 2003)

Upregulation of HLA Class I Expression on Tumor Cells by the Anti-EGFR Antibody Nimotuzumab.

scientific article published on 6 October 2017

List of works by Angel Garcia-Lora

A new extract of the plant Calendula officinalis produces a dual in vitro effect: cytotoxic anti-tumor activity and lymphocyte activation

A novel preclinical murine model of immune-mediated metastatic dormancy.

Alterations of HLA class I expression in human melanoma xenografts in immunodeficient mice occur frequently and are associated with higher tumorigenicity.

Cancer immune escape: implications for immunotherapy, Granada, Spain, October 3-5, 2011

Class II transactivator-induced MHC class II expression in pancreatic cancer cells leads to tumor rejection and a specific antitumor memory response.

Different regulation of PKC isoenzymes and MAPK by PSK and IL-2 in the proliferative and cytotoxic activities of the NKL human natural killer cell line.

Differential effect of protein-bound polysaccharide (PSK) on survival of experimental murine tumors

Effect of thyroid hormone-nitric oxide interaction on tumor growth, angiogenesis, and aminopeptidase activity in mice

Generation of MHC class I diversity in primary tumors and selection of the malignant phenotype.

HLA and melanoma: multiple alterations in HLA class I and II expression in human melanoma cell lines from ESTDAB cell bank.

Identification of the protein components of protein-bound polysaccharide (PSK) that interact with NKL cells.

International conference: progress in vaccination against cancer-2006 (PIVAC 6), Granada, Spain.

MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to Immunotherapy.

MHC class I antigens and immune surveillance in transformed cells.

MHC class I antigens, immune surveillance, and tumor immune escape.

MHC class I molecules act as tumor suppressor genes regulating the cell cycle gene expression, invasion and intrinsic tumorigenicity of melanoma cells.

MHC class I-deficient metastatic tumor variants immunoselected by T lymphocytes originate from the coordinated downregulation of APM components.

Metastases in immune-mediated dormancy: a new opportunity for targeting cancer

Preclinical modeling of EGFR-specific antibody resistance: oncogenic and immune-associated escape mechanisms.

Protein-bound polysaccharide K and interleukin-2 regulate different nuclear transcription factors in the NKL human natural killer cell line.

Restoration of MHC-I on Tumor Cells by Fhit Transfection Promotes Immune Rejection and Acts as an Individualized Immunotherapeutic Vaccine

Role of altered expression of HLA class I molecules in cancer progression.

Selective upregulation of MHC class I expression in metastatic colonies derived from tumor clones of a murine fibrosarcoma.

T lymphocytes restrain spontaneous metastases in permanent dormancy.

The immunomodulator PSK induces in vitro cytotoxic activity in tumour cell lines via arrest of cell cycle and induction of apoptosis

The pro-oxidant buthionine sulfoximine (BSO) reduces tumor growth of implanted Lewis lung carcinoma in mice associated with increased protein carbonyl, tubulin abundance, and aminopeptidase activity

The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape.

The tumour suppressor Fhit positively regulates MHC class I expression on cancer cells ⬇️

The urgent need to recover MHC class I in cancers for effective immunotherapy

Total loss of HLA class I expression on a melanoma cell line after growth in nude mice in absence of autologous antitumor immune response.

Tumour immunology, vaccination and escape strategies

Upregulation of HLA Class I Expression on Tumor Cells by the Anti-EGFR Antibody Nimotuzumab.